American Heart Association
Late-Breaking Science: In-Depth with CLEAR SYNERGY
Late-Breaking Science In-Depth
S106A
Nov 18th , 09:45 AM - 10:30 AM
09 : 45 AM
In-Depth: The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction. The results of the spironolactone factorial
Jolly Sanjit, D'entremont Marc-andre
Final Pr. ID: -
Authors: Jolly Sanjit, D'entremont Marc-andre
09 : 45 AM
In-Depth: The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction. The results of the spironolactone factorial
Jolly Sanjit, D'entremont Marc-andre
Final Pr. ID: -
Authors: Jolly Sanjit, D'entremont Marc-andre